$48.87
2.134.56%
At close: -
$48.87
-0.000500.00%
After Hours: Dec 20, 4:00 PM EDT
Cytokinetics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cytokinetics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $-1.36 | $-1.26 | -7.94 % |
Jun 2024 | 2024-08-08 | $-1.31 | $-1.06 | -23.6 % |
Mar 2024 | 2024-05-08 | $-1.33 | $-1.14 | -16.7 % |
Dec 2023 | 2024-02-27 | $-1.38 | $-0.97 | -42.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $463.00K | $1.20M | -61.3 % |
Jun 2024 | 2024-08-08 | $249.00K | $920.00K | -72.9 % |
Mar 2024 | 2024-05-08 | $835.00K | $900.00K | -7.22 % |
Dec 2023 | 2024-02-27 | $1.67M | $10.77M | -84.5 % |
Cytokinetics (CYTK) is scheduled to report earnings on February 25, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
The Actual EPS was $-1.36, which missed the estimate of $-1.26.
The Actual Revenue was $463K, which missed the estimate of $1.2M.
Browse earnings estimates, EPS, and revenue on all stocks.